Ipsen’s commitment to oncology is demonstrated by its growing portfolio of therapies aimed at improving the lives of patients with neuroendocrine tumors, bladder, kidney cancer, pancreatic and breast cancers.


Rare Diseases

Ipsen continues to develop innovative medicines in rare diseases to address conditions with high unmet needs, with specific investment in pituitary pathologies and growth disorders.


Ipsen is a key player in the treatment of movement disorders. The group is committed to improving the mobility, independence and quality of life of patients with these very disabling disorders. Ipsen’s consolidated expertise in the field of neurotoxins dates back over 25 years.

Black mother with baby reading pill bottle

Consumer Healthcare

In Consumer Healthcare, Ipsen offers treatments for gastrointestinal disorders, neurodegenerative pathologies, and rheumatology. Ipsen has had a strong presence in international markets in this field for many years.

Last update 20/11/2017